Pregnancy loss is more common than many expect. Approximately 25% of all pregnancies end in miscarriage, with the risk increasing significantly with maternal age. Women aged 20–35 years face a ~10% risk, whereas those aged 35–40 years experience a loss in up to 50% of pregnancies. In many cases, repeated miscarriage—also known as recurrent pregnancy loss (RPL)—is linked to underlying chromosomal or genetic abnormalities
At Labassure, we understand the clinical and emotional complexity surrounding RPL. That’s why we offer a comprehensive suite of cytogenetic and molecular diagnostic tests to uncover hidden causes, guide reproductive counseling, and support informed planning for future pregnancies.
Unlike general screening, these are diagnostic tests that investigate whether chromosomal abnormalities in the parents or the fetus may be contributing to recurrent losses. Testing is conducted on peripheral blood or products of conception (POC), depending on the clinical context.
Supporting women in understanding reproductive health, hormonal balance, and fertility potential with advanced diagnostic panels and hormone assessments.